-
Home
- About PMI
-
Smoke-free approach
- What is harm reduction?
- Absence of combustion
- Nicotine
- The role of smoke-free products
- Tar
- Tobacco Regulation
Smoke-free approachOffering smoke-free alternatives to adult smokers is a sensible, complementary addition to existing tobacco control strategies.Read More -
Research
- PMI’s studies on smoke-free products
- Our Findings
- PMI Publications Library
- Literature Reviews
- Independent Studies
- Investigator Initiated Studies (IIS)
- PMI Science Booklet
- Facts and figures on our smoke-free future
ResearchExplore our product assessment program, its results, and the publications where they are published. Find a wealth of independent research and expert reports.Read More -
Our Products
- Tobacco Heating System
- Oven Heating System
- Ceramic Vaping System
- Disposable Vaping System
- Oral Nicotine Pouches
- Nicotine salts product
Our ProductsPMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.Read More -
News & Events
- Scientific Update Magazine
- Open Science Events
- News
- Conferences Calendar
- Media Library
News & EventsRead our most recent articles and catch up on our latest events and conference presentations.Read More - Contact Us
Cross-Sectional Survey on the Use of Tobacco Products - London (UK)
Cross Sectional Survey on the Use of Tobacco Products in the General Population and in Users of IQOS in London (2018-2020)
The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in London, United Kingdom.
Recruitment: Recruiting
Study Results: No Results Available
Enrollment: 7331 (estimated)
Study Type: Observational
Other IDs: P1-PMX-04-UK
3D‐Pictogram of Risk Measures in Epidemiology
A novel approach to assess the population health impact of introducing a Modified Risk Tobacco Product
IQOS Use Prevalence and History of Tobacco Product Use: Findings from Surveys in Japan, Italy, and Germany
IQOS uptake and history of tobacco product use: findings from cross-sectional surveys in Japan, Italy, and Germany
Post-market evidence on alternative nicotine-containing products
Considerations when using sales volume data to estimate tobacco product substitution effects
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.